UMU logo

Umeå University EC Jubilee Symposium - The MIMS Excellence by Choice Programme

Welcome to the University's EC Jubiliee Symposium!
Friday 16 October 2015, Aula Nordica, 13.30-16.30

“What enables groundbreaking research? What might attract the next generation of researchers? These questions are of fundamental importance to research and will be highlighted and discussed at the symposium Excellence by Choice.

Invited speakers include internationally leading scientists and research directors involved in recruitment and scientific policy guiding. Young group leader colleagues share their experience together with the successful MIMS group leader and role model Emmanuelle Charpentier, now known worldwide for her research on CRISPR-Cas9, a groundbreaking genome editing tool. The symposium is organised by Umeå University and its Laboratory for Molecular Infection Medicine Sweden – MIMS – the Swedish node in The Nordic EMBL Partnership for Molecular Medicine.

Find more information and biographies of the speakers on the Website of Umeå University:

See Press Release from Umeå University (2015-06-24)

Excellence by Choice for scientific renewal at EMBL and our partnerships
Iain Mattaj, Professor, Director General EMBL, The European Molecular Biology Laboratory, Heidelberg, Germany.

The Global Challenge of infections: A research area of continued excellence at Umeå University
Jörg Hacker, Professor, President, German National Academy of Sciences Leopoldina, Germany.

Just joined Umeå University: A Choice made by both me and MIMS
Andrea Puhar, PhD, Group Leader MIMS, The Laboratory for Molecular Infection Medicine Sweden, Umeå University.

The Umeå University EC Jubilee Award 2015: ”The MIMS Excellence by Choice Programme”
Lena Gustafsson, Professor, Vice-Chancellor Umeå University.

From Asilomar to Umeå: From gene cloning to genome editing
Ernst-Ludwig Winnacker, Professor, Gene Center,
Ludwig Maximilian University, Munich, Germany.

The CRISPR-Cas9 revolutionary genome engineering technology: Lessons from bacteria
Emmanuelle Charpentier, Professor, Max Planck Institute for Infection Biology Berlin, Germany,
Helmholtz Centre for Infection Research, Hannover Medical School, Germany, Visiting Professor and
Group Leader MIMS, Umeå University.

CRISPR-Cas9: An excellent tool for our leukemia research
Dirk Heckl, Assistant Professor, Junior Research Group Leader,
Department of Pediatric Hematology and Oncology, Hannover Medical School, Germany.

Panel discussion:
with Emmanuelle Charpentier, Professor. Andrea Puhar, PhD. Anna Överby Wernstedt, Associate Professor,
Group Leader MIMS, Umeå University.
Ernst-Ludwig Winnacker, Professor. Bernt Eric Uhlin, Professor, Director MIMS, Umeå University.

Emmanuelle Charpentier took the Nobel Prize in Chemistry

Emmanuelle has been awarded jointly with Jennifer Doudna the 2020 Nobel Prize in Chemistry for discovering the groundbreaking CRISPR-Cas9 gene editing technology. She is a former group leader at MIMS, honorary doctor at Umeå University and former visiting professor at UCMR.

Movie by Knut and Alice Wallenberg Foundation (

Battling antibiotic resistance

movie by Knut and Alice Wallenberg Foundation, with participation of scientists from MIMS and UCMR:
Or watch the original movie on:

Research about infectious diseases:

Oliver Billker in movie of Knut and Alice Wallenberg Foundation:
Or watch the original movie on:

footer all slides 2014-02-06

Copyright © 2019 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.